![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
1. The metabolism of norethynodrel was investigated in four women. In seven days following oral administration, 40% of the dose was excreted in the urine and 34% in the faeces, predominantly in conjugated form. The urinary half-life was 11 h.
2. Fractionation of the urinary metabolites revealed a complex and extensive metabolic pattern. The metabolites isolated and identified from the less polar fractions were: 17α-ethynylestr-5(10)-ene-3α,17β-diol (1.8% total urinary radioactivity); 17α-ethynylestr-5(10)-ene-3β,17β-diol (4.7%); 17α-ethynyl-5β-estrane-3α,17β-diol (1.0%); and 17α-ethynyl-5α-estrane-3β,17β-diol (2.3%), unchanged norethynodrel was not isolated.